REGENEREX PHARMA, INC. (RGPX)
↓ Download CSV- Sector Manufacturing
- Incorporated NV
- Fiscal year ends Dec 31
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $1.8K | $2.6K | — | — | — | — |
| Cost of Revenue | — | — | — | — | $246.7K | $1.7K | — | — | — | — |
| Gross Profit | — | — | — | — | -$244.9K | $896 | — | — | — | — |
| Operating Income | -$1.83M | -$3.47M | -$96.2K | -$126.3K | -$43.4K | -$77.0K | -$91.7K | -$49.5K | -$2.6K | — |
| Net Income | -$2.53M | -$3.54M | -$137.3K | -$195.6K | -$353.8K | $111.6K | -$93.6K | -$49.7K | -$2.6K | — |
| Total Assets | $1.26M | $766.7K | $6.5K | $15.3K | $10.5K | $259.2K | $105.6K | $15.1K | — | — |
| Total Liabilities | $5.42M | $4.83M | $1.13M | $1.00M | $845.5K | $740.4K | $475.3K | $336.2K | — | — |
| Shareholders' Equity | -$4.16M | -$4.06M | -$1.12M | -$985.6K | -$835.0K | -$481.3K | -$369.7K | -$321.1K | -$321.1K | -$279.1K |
| Cash & Equivalents | $653.0K | $372 | $1.1K | $2.6K | $6.9K | $5.5K | $88.5K | $1.7K | — | — |
| Operating Cash Flow | -$1.63M | -$457.5K | -$76.2K | -$69.9K | -$62.7K | -$291.2K | $47.1K | $36.1K | $2.6K | — |
| Shares Outstanding | 281.07M | 278.23M | 277.11M | 277.11M | 127.11M | 127.11M | 127.11M | 127.11M | 156.06M | — |